In the spirit of not just publishing fluff when things go right, I thought I’d pen a few notes on Fusion Antibodies (FAB) as they provided a trading update this week and I am a shareholder! I’ve actually completed a couple of research notes on the company recently, the latest part here As I writeContinue reading “Some FAB some not so…”